AQUILA BIOMEDICAL LIMITED

Company number SC393914

Date	Type	Description	View / Download
08 Oct 2021	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/20	(3 pages)
08 Oct 2021	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/20	(1 page)
30 Apr 2021	CS01	Confirmation statement made on 21 February 2021 with updates	(4 pages)
25 Mar 2021	SH20	Statement by Directors	(1 page)
25 Mar 2021	SH19	Statement of capital on 25 March 2021 GBP 0.001	(3 pages)
25 Mar 2021	CAP-SS	Solvency Statement dated 17/03/21	(1 page)
25 Mar 2021	RESOLUTIONS	Resolutions RES13 ‐ Share premium account cancelled 17/03/2021 RES06 ‐ Resolution of reduction in issued share capital	(1 page)
15 Oct 2020	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/19	(176 pages)
02 Oct 2020	AP01	Appointment of Mr Steven Francis Axtell Horder as a director on 18 September 2020	(2 pages)
02 Oct 2020	TM01	Termination of appointment of Matthew James Hanson as a director on 18 September 2020	(1 page)
28 Sep 2020	AA	Audit exemption subsidiary accounts made up to 31 December 2019	(24 pages)
28 Sep 2020	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/19	(1 page)
28 Sep 2020	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/19	(3 pages)
31 Jul 2020	AD01	Registered office address changed from Addleshaw Goddard Llp Exchange Tower 19 Canning Street Edinburgh EH3 8EH United Kingdom to 2 James Lindsay Place Dundee DD1 5JJ on 31 July 2020	(1 page)
23 Mar 2020	CS01	Confirmation statement made on 21 February 2020 with no updates	(3 pages)
23 Mar 2020	TM01	Termination of appointment of Paul Mccluskey as a director on 31 December 2019	(1 page)
18 Mar 2020	RESOLUTIONS	Resolutions RES01 ‐ Resolution of adoption of Articles of Association	(27 pages)
23 Jan 2020	TM01	Termination of appointment of Clare Louise Doris as a director on 8 October 2019	(1 page)
23 Jan 2020	TM01	Termination of appointment of Stephen Mark Anderton as a director on 5 August 2019	(1 page)
04 Nov 2019	TM01	Termination of appointment of John William Handley as a director on 10 September 2019	(1 page)
11 Oct 2019	AA	Audit exemption subsidiary accounts made up to 31 December 2018	(23 pages)
11 Oct 2019	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/18	(167 pages)
11 Oct 2019	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/18	(1 page)
11 Oct 2019	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/18	(3 pages)
20 Aug 2019	AP01	Appointment of Matthew James Hanson as a director on 5 August 2019	(2 pages)